Economiic Home Method Watch Market RSI Search

ProKidney Corp. PROK

Sector:

Healthcare

Industry:

Biotechnology

Description:

ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. It is developing Renal Autologous Cell Therapy, an autologous homologous cell admixture that is in a Phase III development program, as well as Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease; and Phase I clinical trial for patients with congenital anomalies of the kidney and urinary tract. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.
ProKidney Corp. website

Recent Quarter:

2024-11-12

Upcoming Quarter:

2025-03-20

Annual Reports

Date2024-03-22
Revenue 0
Net Income -35,468,000
EPS -0.57
Basic Shares 61,714,000
Diluted Shares 61,714,225
Report Link
Date2023-03-28
Revenue 0
Net Income -148,135,000
EPS -2.41
Basic Shares 61,540,231
Diluted Shares 61,540,231
Report Link
Date2022-03-24
Revenue 0
Net Income -55,146,000
EPS -0.3
Basic Shares 186,500,000
Diluted Shares 186,500,000
Report Link
Date2020-12-31
Revenue 0
Net Income -26,749,000
EPS -0.14
Basic Shares 186,500,000
Diluted Shares 186,500,000
Report Link
Date2019-12-31
Revenue 0
Net Income -79,615,000
EPS -1.01
Basic Shares 78,526,000
Diluted Shares 78,526,027
Report Link

Annual Ratios

Date2023-12-31
PE -3.10
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-12-31
PE -2.85
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-12-31
PE -33.48
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-12-31
PE -70.49
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-12-31
PE -9.97
Dividend Yield 0.00
Payout Ratio: 0.000%

Quarterly Reports

Date2024-11-12
Revenue 0
Net Income -23,143,000
EPS -0.18
Basic Shares 126,173,463
Diluted Shares 126,173,463
Report Link
Date2024-08-09
Revenue 0
Net Income -12,506,000
EPS -0.16
Basic Shares 75,908,017
Diluted Shares 75,908,017
Report Link
Date2024-05-10
Revenue 0
Net Income -9,492,000
EPS -0.16
Basic Shares 60,951,721
Diluted Shares 60,951,721
Report Link
Date2024-03-22
Revenue 4,494,000
Net Income -5,701,000
EPS -0.0952
Basic Shares 59,880,347
Diluted Shares 59,880,347
Report Link
Date2023-11-14
Revenue 0
Net Income -31,007,000
EPS -0.5
Basic Shares 61,592,876
Diluted Shares 61,592,876
Report Link
Date2023-08-10
Revenue 0
Net Income -9,118,000
EPS -0.14
Basic Shares 64,562,209
Diluted Shares 64,562,209
Report Link
Date2023-05-11
Revenue 0
Net Income -36,909,000
EPS -0.6
Basic Shares 61,540,231
Diluted Shares 61,540,231
Report Link
Date2023-03-28
Revenue 0
Net Income -24,573,000
EPS -0.4
Basic Shares 61,540,231
Diluted Shares 61,540,231
Report Link
Date2022-11-14
Revenue 0
Net Income -11,928,000
EPS -0.19
Basic Shares 61,540,231
Diluted Shares 61,540,231
Report Link
Date2022-08-12
Revenue 0
Net Income -22,131,000
EPS -0.36
Basic Shares 61,540,231
Diluted Shares 61,540,231
Report Link
Date2022-05-16
Revenue 0
Net Income -67,486,000
EPS -0.1248
Basic Shares 31,890,000
Diluted Shares 31,890,000
Report Link
Date2022-03-24
Revenue 0
Net Income -13,670,000
EPS -0.0648
Basic Shares 31,890,000
Diluted Shares 31,890,000
Report Link
Date2021-11-15
Revenue 0
Net Income -17,142,000
EPS -0.0079
Basic Shares 31,890,000
Diluted Shares 31,890,000
Report Link
Date2021-08-16
Revenue 0
Net Income -12,725,000
EPS -0.0682
Basic Shares 31,965,000
Diluted Shares 31,965,000
Report Link
Date2021-03-31
Revenue 0
Net Income -11,609,000
EPS -0.0622
Basic Shares 32,265,000
Diluted Shares 32,265,000
Report Link

Quarterly Ratios

Date2024-09-30
PE -2.62
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2024-06-30
PE -3.79
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2024-03-31
PE -2.57
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-12-31
PE -4.67
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-09-30
PE -2.27
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-06-30
PE -19.81
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-03-31
PE -4.72
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-12-31
PE -4.30
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-09-30
PE -11.62
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-06-30
PE -6.92
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-03-31
PE -1.17
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-12-31
PE -5.77
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-09-30
PE -4.56
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-06-30
PE -6.35
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-03-31
PE -7.02
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2001-09-30
PE 0.00
Dividend Yield 0.00
Payout Ratio: 0.000%

RSI:

34.98

Price:

$1.80

Market Cap:

525,077,863

EPS TTM:

-0.60

PE Ratio:

-4.09

PEPSG:

NaN

Fwd PE:

NaN

Volume:

683,634

2 Year Price Change

0.199

Index 2 Year Price Change

1.497

5 Year Price Change

No Price 5 Years Ago

Index 5 Year Price Change

1.905
PESPG: Growth Rate of EPS projected to next quarter and 6 months trailing. Lower is better to help calculate nexts quarters PE Ratio today. Diluted shares effects the EPS reported and makes calculation show as extremely poor expected growth.

Revenue

Net Income

EPS

Shares

News

Press Releases

Notable Earnings

Please select an option: